# A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19

> **NCT04349631** · PHASE2 · COMPLETED · sponsor: **Hope Biosciences Research Foundation** · enrollment: 51 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** HB-adMSCs

## Key facts

- **NCT ID:** NCT04349631
- **Lead sponsor:** Hope Biosciences Research Foundation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-20
- **Primary completion:** 2020-11-25
- **Final completion:** 2020-11-25
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349631, "A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04349631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*